Funding

SECTION I: ESTIMATION OF COSTS

 

1 Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
~20,000€=4×5,000€ (4 European patents)
…in terms of product development
Testing needs will be decided on a case by case basis (testing)163,200€ (development)

-          120,000€=24×5,000€ (24 person months of an experienced researcher, MSc or PhD)

  • o        12 months’ salary to 2 experienced researchers for conducting further research and superintend development.

-          43,200€=24×1,800€ (24 person months of an experienced developer)

  • o        12 months’ salary to 2 experienced developers.
…in terms of mass production
10,000€=5×2,000€ (A cluster of 3-5 high performance PCs with up to 100 TB HDs with fast access and data protection but it depends on the content)
… in terms of marketing
- (standard cost of marketing for a specialized medical informatics software product)

 

2 Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs 
  Year 1 Year 2 Year 3 Year 4 Year 5
Fixed costs 10,000€ - - - -
Personnel 163,200€ - - - -
Other running costs - - - - -
Marketing costs ? ? ? ? ?
TOTAL EXPECTED COSTS 173,200€ - - - -
Price per Unit ? ? ? ? ?
Type of Unit ?
Number of Units ? ? ? ? ?
TOTAL Expected Revenues ? ? ? ? ?
CASH FLOW REQUIRED (REVENUES-COSTS) ? ? ? ? ?
TOTAL CAPITAL required for five years ~200,000€
             

 

 

SECTION 2: QUALITATIVE FACTORS

 

3 Dimension of identified target groups
-          Digital content providers, news agencies, cultural heritage organizations.-          Search engine providers.

 

4 Evaluation of financial Risks for R&D result
Low risks since development of product does not require high expenses.

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

1. European FundingDefine relevance of the product with the following potential funding sources and comment
1. 2.

3.

4.  

 

2. National Funding
1. 2.

3.

 

3. Private funding
1. 2.

3.

 

4. Other
 

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
Creation of spin-off.

Decision of evaluation (Please keep only the appropriate)

  • ·         The R&D has a high potential of exploitation
  • ·         The R&D result needs minor revisions
  • ·         The R&D result needs moderate revisions
  • ·         The R&D result needs major revisions
  • ·         The R&D result has no potential of exploitation
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project